OVERVIEW

Osteoporosis Therapy in 2019-Focus on Anabolics is organized by National Osteoporosis Foundation (NOF).

Start Date: May 15, 2019
Expiration Date: Dec 31, 2021

Accreditation:
The National Osteoporosis Foundation is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The National Osteoporosis Foundation designates this educational activity for a maximum of 0.75 AMA PRA Category 1 Credit(s). Physicians should only claim credit commensurate with the extent of their participation in the activity.
The National Osteoporosis Foundation is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. The National Osteoporosis Foundation designates this educational activity for a maximum of 0.75 continuing nursing education credit(s)
Other healthcare providers will also be able to receive a certificate of completion; nurse practitioners and physician assistants may request an AMA PRA Category 1 Credit(s)™ certificate of participation.

Course Description:
This session will go over challenges in osteoporosis treatment and rationale for anabolic agents for high risk patients.

Learning Objectives:
• List challenges in osteoporosis treatment in 2019
• Identify highest risk patients and determine best treatment methods
• Discuss rational for anabolic agents as initial therapy for high risk patients